Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04009109 |
| Title | Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Alliance Foundation Trials, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northern Light Eastern Maine Medical Center | Bangor | Maine | 04401 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| University of Nebraska Medical Center | Omaha | Nebraska | 68152 | United States | Details | |
| SUNY Upstate Medical Center | Syracuse | New York | 13210 | United States | Details | |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | United States | Details | |
| Gibbs Cancer Center & Research Institute/Spartanburg Regional Healthcare | Spartanburg | South Carolina | 29303 | United States | Details |